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Background: Data collected in clinical trials have been used to develop scoring systems that identify adults with
malaria at greatest risk of death. One of these, the RCAM score, can be simply determined by measuring a patient’s
Glasgow Coma Score and respiratory rate on admission to hospital. However the safety of using the RCAM score to
define high-risk patients has not been assessed outside of the clinical trial setting.
Methods: A retrospective audit of medical records of all adults admitted with a diagnosis of malaria to two tertiary
referral hospitals in Lower Myanmar in 2013 was undertaken. An RCAM score was calculated in all patients and
related to their subsequent clinical course.
Results: The recent decline in malaria hospitalizations at both sites continued in 2013. During the year 90 adults
were hospitalized with malaria; 62 (69%) had Plasmodium falciparum mono-infection, 11 (12%) had Plasmodium
vivax mono-infection, 17 (19%) had mixed infection. All seven (7.7%) deaths occurred in patients infected with
P. falciparum. An admission RCAM score <2 identified all the patients that would survive to discharge (positive predictive
value (95% confidence interval (CI)) 100% (94.9-100%) and also predicted a requirement for less supportive care: 9/70
(13%) patients with an admission RCAM score <2 required supportive care (blood transfusion, vasopressor support or
oxygen supplementation) during their hospitalization compared with 12/20 (60%) patients with an admission RCAM
score ≥2 (p < 0.0001). No patient with P. vivax mono-infection required supportive care during their
hospitalization. Patients with an oxygen saturation ≤95% on room air on admission were more likely to die before
discharge (odds ratio 17.3 (95% CI: 2.9-101.2) than patients with a higher oxygen saturation (p = 0.002).
Conclusions: Even outside a clinical trial setting the RCAM score reliably identifies adults with malaria who are at
greatest risk of death and can be safely used in the initial triage and management of these patients.
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In an effort to reduce malaria-related mortality, the
World Health Organization (WHO) has proposed cri-
teria to define severe malaria, recommending that pa-
tients meeting these criteria receive prompt parenteral
anti-malarial therapy and supportive treatment on an
acute medical ward [1]. Earlier iterations of this defin-
ition [2,3] had limited practical utility: the sheer number* Correspondence: drjoshhanson@gmail.com
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unless otherwise stated.of criteria (16 in the 2012 handbook) made its everyday
use challenging. In addition strongly prognostic indices
(metabolic acidosis) were listed alongside indices of lim-
ited prognostic value (prostration); manifestations appear-
ing predominantly in adults (pulmonary oedema, renal
impairment) were recorded next to those relevant
mainly to the paediatric population (severe anaemia);
and some criteria were relatively uncommon (haemo-
globinuria and abnormal spontaneous bleeding). Per-
haps most importantly however, many of the criteria
required laboratory and radiology services that are
rarely available in a resource-limited setting whereThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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managed [4]. Recognizing these shortcomings, the most
recent WHO consensus statement on severe malaria
has placed a greater emphasis on clinical assessment in
an effort to provide more practical guidance for health
workers [1]. It is suggested that in a resource-limited
setting patient management can be guided – at least
initially – by findings at the bedside.
It has repeatedly been shown that the degree of meta-
bolic acidosis in patients with malaria is strongly predict-
ive of a complicated course and death [5-8]. As the
physiological response to this metabolic acidosis is
hyperventilation [9], the respiratory rate can be used as
a crude bedside measure of acidosis [8]. The other main
determinant of outcome with malaria is the level of con-
sciousness [8,10,11], measured with the Glasgow Coma
Score (GCS). The GCS and the respiratory rate are com-
bined in adults to calculate the RCAM score, a clinical
prediction tool that can be calculated at the bedside by
even inexperienced health workers in less than 60 sec-
onds (Table 1) [8]. When applied retrospectively to pa-
tients enrolled in studies of adults with malaria the
RCAM score calculated at admission helped identify the
patients that were more likely to survive [8,11], poten-
tially facilitating their triage and the distribution of lim-
ited health resources [12].
The clinical trials that generated data for previous
studies assessing the RCAM score were all performed in
poorly resourced hospitals; however the patients in these
studies were not receiving usual care. Some studies oc-
curred in a specialized research ward [13], others used
point of care testing which allowed clinicians more
timely access to a broad range of pathology results [14];
almost all the studies had dedicated study clinicians and
financial resources that would not be accessible outside
of the trial setting. To determine if the RCAM score
might be a reliable tool in the everyday management of
adults with malaria in a resource-limited setting, a retro-
spective audit of all adult cases of malaria admitted to
two referral hospitals in Myanmar was performed.
Methods
Study sites
The audit was comprised of adults admitted to Hpa-an
Hospital and Insein General Hospital with a diagnosis
of malaria between 1 January and 31 December, 2013.Table 1 Calculation of the RCAM score
Score
Variable 0 (normal) 1 (abnormal) 2 (very abnormal)
GCS 15 11 to 14 (inclusive) ≤10
Respiratory rate <20 20 to 39 (inclusive) ≥40
RCAM score (0–4) is calculated as the respiratory rate score (0–2) plus the GCS
score (0–2).Hpa-an Hospital is the largest hospital in Kayin state
(population 1.57 million), a state that neighbours Thailand
to the east. Insein General Hospital is one of seven major
public general hospitals in the Yangon region (population
5.6 million). The two hospitals serve populations in which
there is low transmission of malaria. Cases occur year
round although there is a peak in transmission during the
mid-year wet season. At Hpa-an Hospital patients are
generally socio-economically disadvantaged and live pre-
dominantly in surrounding rural villages; Insein General
Hospital serves a predominantly urban population, which
is also socio-economically disadvantaged.Limited resource setting
Laboratory services are limited at both sites; accordingly
many laboratory tests are not routinely collected. Basic
biochemistry (including plasma electrolytes, blood urea
nitrogen, plasma creatinine, and liver function tests) can
be measured and a full blood examination performed,
however the laboratory services in both hospitals are
only routinely available between 08.00 and 16.00 hours
and six hours usually elapse before results are available.
Private laboratories can provide out of hours results,
however the extra cost of this service precludes its use
by the vast majority of patients at both sites. Even if the
patients have sufficient funds to access the private sys-
tem, as specimens must be transported off site, results
are rarely available within six hours. Plasma lactate can-
not be measured at either hospital or in local private la-
boratories. Thick and thin blood films for malaria can be
performed at any time of day, but as there is a turn-
around time of several hours, clinicians usually rely on
rapid diagnostic tests (RDTs) to make the diagnosis if
the clinical suspicion is high.
Other diagnostic services and supportive care are also
limited. Both hospitals have a radiology department where
plain X-rays can be performed on a stable, portable pa-
tient; however neither site can perform mobile X-rays.
Both sites lack facilities for renal replacement therapy
(RRT) and neither have a functioning intensive care unit
(ICU). Patients in Insein Hospital who require RRT must
be transferred 25 km (one hour by road) although it is not
logistically possible to transfer an acutely critically ill pa-
tient. Patients admitted to Hpa-an Hospital are at least
five hours by motorway from the nearest unit providing
RRT, which means that delivery of this therapy to the
acutely ill patient is effectively impossible.Ethical approval
Ethical approval was granted for this audit by the
Myanmar Ministry of Health and by the Menzies School
of Health Research.
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Data were retrospectively collected from medical records.
Malaria was diagnosed with immunochromatographic
RDTs (SD Bioline Malaria Ag P.f/P.v (05FK80), Standard
Diagnostics, Republic of Korea). The malaria diagnosis
and species was confirmed using semi-quantitative thick
and thin films read by experienced technicians in the hos-
pital laboratories. Demographic, clinical and laboratory
data were entered into a standardized data collection form
and entered into an anonymous database. Severity criteria
from the 2012 WHO practical handbook for the manage-
ment of severe malaria [2] were specifically sought in the
medical record.Statistical analysis
Statistical analysis was performed using statistical soft-
ware (Stata 10.0, Statacorp, Texas USA). Groups were
analysed using the Kruskal-Wallis and Chi-squared tests.Figure 1 Incidence of malaria hospitalization at the two study sites sinc
documents only adults admitted to the medical ward. Data source: personal c
Planning, Ministry of Health, Myanmar.Results
From 1 January to 31 December, 2013, 90 patients were
admitted to hospital with malaria at the two study sites;
56 at Hpa-an Hospital and 34 at Insein Hospital; this rep-
resented a continued decline in malaria hospitalization at
both sites (Figure 1). There were few differences between
patients at the study sites (Table 2), although patients ad-
mitted to Insein Hospital were more likely to have a his-
tory of travel in the previous four weeks (82 versus 11%,
p = 0.0001). No patient had a RCAM score documented in
the medical record, but all patients had a GCS and re-
spiratory rate recorded on admission permitting its retro-
spective determination.
Overall 7/90 (8%) of patients in the series died; deaths
tended to occur early in patients’ hospitalization with
5/7 (71%) occurring within the first 24 hours. All deaths
occurred in patients infected with Plasmodium falcip-
arum. The median (IQR) age of the patients that died
was 32 (24–39) years; only 3/7 (43%) had co-morbiditiese 2005*. * Includes all patients admitted to the hospital while the audit
orrespondence Dr Thet Thet Mu, Deputy Director, Department of Health
Table 2 Characteristics of the cases admitted to the adult medical ward
Variable* Total Insein Hpa-an p^
Number of cases 90 34 56
Male sex 63 (70%) 29 (85%) 34 (61%) 0.02
Age (years) 34 (21–42) 31 (19–37) 35 (23–51) 0.17
Significant co-morbidities 20 (22%) 11 (32%) 9 (16%) 0.07
Duration of admission (days) 6 (4–8) 6 (4–8) 6 (4–7) 0.31
Died 7 (8%) 3 (9%) 4 (7%) 1
P. falciparum mono-infection 62 (69%) 24 (71%) 38 (68%) 0.79
P. vivax mono-infection 11 (12%) 5 (15%) 6 (11%) 0.57
Mixed infection 17 (19%) 5 (15%) 12 (21%) 0.43
Number of WHO severity criteria 2 (1–3) 2 (1–3) 2 (1–2) 0.69
RCAM score 1(1–1) 1 (1–2) 1(1–1) 0.48
History of travel in prior 4 weeks 34 (38%) 28 (82%) 6 (11%) <0.001
*All numbers represent the raw number (%) or the median (interquartile range).
^Statistical difference between the two study sites.
Figure 2 Ability of the RCAM score to predict outcome in this and previous series [11,14].
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Table 3 RCAM score on admission and association with
outcome
RCAM score Survivors Deaths All
0 16 0 16
1 55 (98.2%) 0 55
2 8 (80%) 2 (20%) 10
3 5 (56%) 4 (44%) 9
4 0 1 (100%) 1
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spectively). No patients with a RCAM score <2 on admis-
sion died (positive predictive value for survival 100% (95%
confidence interval: 94.9-100) and the case-fatality rate in-
creased steadily with rising RCAM score (p = 0.0001)
(Figure 2, Table 3). A patient’s RCAM score on admission
was also predictive of a requirement for supportive
therapy: 9/70 (13%) of patients with a RCAM score <2 on
admission required a blood transfusion, vasopressor
support or oxygen supplementation during theirFigure 3 Ability of the RCAM score to predict a requirement for supphospitalization compared with 12/20 (60%) of patients
with a RCAM score ≥2 (p < 0.0001) (Figure 3). A pa-
tient’s admission oxygen saturation (determined with
pulse oximetry) was also a strong predictor of death be-
fore discharge (Table 4). Patients with an admission
oxygen saturation below 96% on room air were far
more likely to die before discharge (odds ratio 17.3
(95% confidence interval 2.9-101.2, p = 0.002); 5/7
(71%) deaths had an oxygen saturation below this level.
The patients that died satisfied a median (IQR) of 4
(3–6) documented WHO severity criteria on admission
compared with 2 (1–2) in survivors (p = 0.0002). The
only WHO criteria that were significantly associated
with outcome in this series were an elevated respiratory
rate (>30 breaths per minute, p = 0.009), impaired GCS
(GCS <15, p < 0.001) and hyperparasitaemia (≥3+ para-
sites on semi-quantitative counting, p = 0.03). The fact
that some of the WHO criteria lacked an association
with mortality was, at least partly, the result of incom-
plete data: haemoglobin and plasma creatinine were notortive care.
Table 4 Prognostic utility of the vital signs in the cases admitted to the adult medical ward in 2013
Variable Survivors (83) Deaths (7) p
Temperature (°C) 38 (37.2-39.1) 38 (36.6-39.6) 0.52
Heart rate (beats per minute) 100 (88–108) 120 (92–128) 0.04
Mean arterial pressure (mmHg) 83.2 (76.5-93.2) 76.6 (59.9-89.8) 0.2
Respiratory rate (breaths per minute) 22 (20–24) 26 (24–36) 0.002
Glasgow Coma Scale 15 (15–15) 9 (8–13) 0.0001
Oxygen saturation (%) 97 (96–98) 93 (87–96) 0.003
All numbers represent the median (interquartile range).
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lactate were not measured at either site. Other severity
criteria occurred infrequently: shock (systolic blood
pressure < 80 mmHg with cool peripheries) was present
in only 3 cases, 2 of which survived.
The majority of patients had P. falciparum mono-
infection: 62/90 (69%) versus 17/90 (19%) with mixed
infection and 11/90 (12%) with vivax mono-infection.
Patients with Plasmodium vivax mono-infection gener-
ally had less severe disease; all 11 patients had prostra-
tion requiring hospitalization; three (27%) were also
jaundiced but these patients all lacked any other organ
dysfunction; one had a history of dark stools suggesting
gastrointestinal bleeding, but there was no bleeding wit-
nessed after hospitalization. No patients with P. vivax
mono-infection had impaired consciousness compared
with 20/79 (27%) of patients with P. falciparum infection
(p = 0.11). Acute kidney injury (AKI) was not suspected
clinically in any of the patients with P. vivax mono-Table 5 Comparison of cases with Plasmodium vivax mono-in
n P. fa
Mortality 90 7 (9%
Duration of hospitalization* (days) 90 6 (4–
Temperature (°C) 90 38 (3
Heart rate (beats per minute) 90 100
Mean arterial pressure (mmHg) 90 83.2
Respiratory rate (breaths per minute) 90 22 (2
Glasgow Coma Scale score 90 15 (1
Oxygen saturation (%) 86 97 (9
Plasma creatinine (μmol/L) 33 92 (6
Haemoglobin (g/dL) 22 7.8 (
Required blood transfusion number (%) 90 13 (1
Required supplemental O2 number (%) 90 8 (10
Required vasopressor support number (%) 90 6 (8%
Acute kidney injury ^ number (%) 33 8 (10
Spontaneous bleeding number (%) 90 12 (1
All numbers represent the raw number (%) or the median (interquartile range).
*Only includes survivors.
^Creatinine documented > 176 μmol/L.infection and the plasma creatinine was normal (range:
62–88 μmol/L) in all five who had a value documented.
By comparison, AKI (plasma creatinine >176 μmol/L)
was present in 8/28 (29%) of patients with P. falciparum
infection with a plasma creatinine recorded. Anaemia
(haemoglobin concentration <11.5 g/dL) was present in
18/20 (90%) of patients with P. falciparum infection who
had a haemoglobin concentration documented; the two
patients with P. vivax mono-infection and a documented
haemoglobin were not anaemic. No patient with P. vivax
mono-infection required supportive care (blood transfu-
sion, supplemental oxygen or vasopressor support) dur-
ing their admission. By contrast supportive care was
required in 21/79 (27%) of patients infected with P. fal-
ciparum (p = 0.06) (Table 5). The median (IQR) duration
of hospitalization in patients with P. vivax mono-
infection was 4 (4–5) days versus 6 (4–8) days in pa-
tients infected with P. falciparum, p = 0.02). All patients
with P. vivax mono-infection had a RCAM score <2.fection with Plasmodium falciparum infection
lciparum (79 cases) P. vivax (11 cases) p
) 0 0.59
8) 4 (4–5) 0.02
7.2-39.1) 38.5 (36.9 -38.5) 0.67
(88–110) 104 (78–120) 0.93
(76.5-93.2) 79.9 (76.5-83.2) 0.45
0–24) 22 (20–24) 0.47
4–15) All cases had GCS 15 0.06
6–98) 98 (98–98) 0.01
4–200) 64 (63–80) 0.16
6.7-9.9) 12.2 (11.7 – 12.6) 0.07
7%) 0 0.16
%) 0 0.59
) 0 0.44
%) 0 0.59
5%) 0 0.35
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Although this clinical audit was conducted at major re-
gional centres in Lower Myanmar, limited diagnostic facil-
ities at both sites precluded the application of many of the
traditional criteria used to identify patients with severe
malaria. However a few simple clinical indices promptly
identified the patients who were at greater risk of a com-
plicated course. Patients’ RCAM score on admission was
strongly linked to outcome. Not only did a RCAM
score ≥2 identify all the patients that would later die, it
also strongly predicted a requirement for supportive care,
potentially allowing triage of these patients to areas in the
hospital where closer monitoring is possible. The mortal-
ity rates with each increment of the RCAM score in pa-
tients receiving everyday care were quantitatively very
similar to those seen in the studies of patients enrolled in
clinical trials [11,12], suggesting generalizability of the
score.
As in previous multi-centre studies of adults with severe
P. falciparum infection, oxygen saturation determined on
admission with pulse oximetry was also a powerful prog-
nostic indicator [12]. Pulse oximetry has been used to
measure arterial oxygen saturation non-invasively for over
30 years [15]. It is used so widely in everyday medical
practice that it is sometimes referred to as the ‘fifth vital
sign’ [16]. Although Plasmodium infection can lead dir-
ectly to acute pulmonary oedema, pulse oximetry has the
advantage of also identifying respiratory co-morbidity, as-
piration pneumonia or concurrent community-acquired
or nosocomial pneumonia, all of which are associated with
high mortality [17-19]. Even a small drop in oxygen satur-
ation in patients with falciparum malaria is significant as
the metabolic acidosis that is frequently present leads to
an increased minute ventilation [18]. In a previous multi-
centre study, patients with saturation of ≤95% were more
than twice as likely to die before discharge [12]; in this
smaller series the odds ratio for death was even greater.
These data support a more prominent role for pulse oxim-
etry in disease management algorithms.
These three clinical signs (GCS, respiratory rate and
pulse oximetry) can be measured by even junior health
care workers. An advantage of management algorithms
using simple clinical signs is that respiratory rate, pulse
oximetry are routinely collected in all hospitalized pa-
tients, while GCS is usually recorded in all those with im-
paired consciousness. This allows integration of patient
care, avoiding complex individual disease care pathways
[20]. This is particularly important as malaria incidence
declines; a derangement in the vital signs is of equal rele-
vance in patients with severe malaria, pre-eclampsia, is-
chaemic heart disease or a head injury. Early recognition
of a change in the vital signs is widely used in the industri-
alized world to promptly identify at-risk patients and has
been shown to improve outcomes [21-23].Although it has been traditionally thought that P. vivax
infection is much less likely to progress to severe malaria
than P. falciparum infection, the notion that P. vivax is a
‘benign’ infection has been vigorously challenged [24,25]
and in the last decade there has been a marked increase in
reports of severe P. vivax infection [26]. Coma, renal fail-
ure, multi-organ failure and death have all been described
[27,28], although there remains uncertainty about the con-
tribution of co-morbidities to these clinical presentations
[26] and few reports have provided population denomina-
tors to estimate their incidence [29]. It is unclear to what
extent this increased documentation is the result of the
emergence of virulent strains, previously underestimated
severity, or a renewed interest in the parasite [30,31]. In
this series hospitalization with P. vivax mono-infection
was not frequent and no case had clinical manifestations
beyond prostration and jaundice; there was no evidence of
the more severe clinical phenotypes described in other
series. It is notable that all the patients with P. vivax
mono-infection had RCAM scores <2 and all survived
without blood transfusion, vasopressor or oxygen support.
These findings are consistent with the rarity of reports of
severe disease in patients with P. vivax mono-infection
from other countries in the Greater Mekong region [1].
The decreasing incidence of malaria requiring hospita-
lization reported in this study parallels the findings of
many centres globally and reflects the success of the Roll
Back Malaria Partnership [32,33]. However Myanmar still
bears a significant – and disproportionate – burden of dis-
ease. In 2012 Myanmar reported 480,000 malaria cases
and while the country is home to less than 3% of South-
east Asia’s population, it is responsible for 49% of the re-
gion’s reported malaria deaths [32]; Myanmar is also the
country most imminently threatened by the evolving re-
sistance to artemisinin therapy [34]. It is likely that clini-
cians in Myanmar will be caring for patients with malaria
for years to come. While the vast majority of cases of mal-
aria will be successfully managed on an outpatient basis,
even young and otherwise healthy individuals can deteri-
orate rapidly: all but one of the patients that died in this
series was younger than 40, over half had no co-morbidities.
While improved access to ICU level care including RRT and
mechanical ventilation will improve outcomes [35], and
strategies are in place in an attempt to increase access to this
care in Myanmar [36], the use of simple inexpensive clinical
management pathways is likely to improve outcomes in the
short term [37].
The study had several major limitations. The audit was
retrospective and accordingly data collection was incom-
plete; limited documentation of some laboratory data in
particular precluded detailed evaluation of its utility in
patient assessment. However, the fact that the data re-
quired for derivation of the RCAM score were docu-
mented in all patients’ records illustrates its potential
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available to confirm the species of the infecting malaria
parasite(s), however the data collected here – presump-
tive speciation with RDT, confirmed by an experienced
microscopist – represents real world practice. Although
clinical indices appeared useful in predicting patients’ in-
hospital course, this does not obviate the need for a strict
and specific case definition which includes laboratory indi-
ces; such a definition is important for clinical researchers,
particularly those studying malaria pathophysiology.
There are also several caveats: although clinical indices
appeared helpful in patient triage this series, laboratory
and radiological investigations remain essential to con-
firm clinical impressions; the study’s findings in no way
suggest that diagnostic laboratory testing can be rou-
tinely deferred. Analysis was performed using only pa-
tient data recorded on admission; even if a patient is
triaged as low-risk this does not preclude the possibility
of complications developing during their hospitalization,
although this did not transpire in this series. The data
were collected in adults in referral hospitals, and do not
necessarily reflect the utility of clinical signs in children
or in other settings. Finally, as in the management of pa-
tients with any illness, the use of prediction tools should
not override a physician’s clinical judgement.
Conclusions
Malaria incidence is declining in Myanmar, however pa-
tients continue to die from falciparum malaria. Early iden-
tification of patients at greatest risk of a complicated
course can facilitate resource allocation and may improve
outcomes. As patients with malaria are almost univer-
sally managed in the resource-poor setting – frequently
by junior health care workers – patient management al-
gorithms should be simple, practical and integrated
with the care of other patients. Triage of patients based
on simple clinical indices appears to achieve these aims
and appears generalizable outside the research setting,
although prospective validation is required to confirm
the safety, accuracy and efficacy of such an approach.
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